Ignite Creation Date:
2025-12-24 @ 10:03 PM
Ignite Modification Date:
2025-12-30 @ 5:50 PM
Study NCT ID:
NCT01205035
Status:
COMPLETED
Last Update Posted:
2015-04-10
First Post:
2010-09-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia
Sponsor:
Eye Center of Northern Colorado, P.C.